Gates Leaves Icos Board

Microsoft ( MSFT) Chairman Bill Gates is giving up his directorship with Icos ( ICOS), a drug developer, to spend more time working on the board of Warren Buffett's Berkshire Hathaway ( BRKa), according to a filing with the Securities and Exchange Commission.

Icos is best known for developing Cialis, a popular drug used to treat erectile dysfunction.

Gates said that Buffett, a longtime friend, asked him to join the Hathaway board shortly before Christmas. "Given my friendship with Warren and my interest in helping out in any way he ever asks, Berkshire is now my highest priority for board membership," Gates wrote in a letter to Icos Chairman Paul Clark.

Gates said he intends to remain a long-term investor in Icos.

More from Technology

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Some Companies Are Already Feeling the Effect of GDPR

Some Companies Are Already Feeling the Effect of GDPR

Experts Break Down GDPR Risks for Investors

Experts Break Down GDPR Risks for Investors

Netflix Ready to Surpass Disney as America's Most Valuable Media Company

Netflix Ready to Surpass Disney as America's Most Valuable Media Company

60 Seconds: What the Heck is GDPR?

60 Seconds: What the Heck is GDPR?